The development of resistance to a potent lipolysis inhibitor, 3-methylisoxazole-5-carboxylic acid.
D000273:Adipose Tissue / Q000378:metabolism; D000315:Adrenalectomy; D000818:Animals; D001322:Autoanalysis; D003998:Dicarboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D005215:Fasting; D005227:Fatty Acids / Q000097:blood* / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats
D003998:Dicarboxylic Acids; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D009539:Nicotinic Acids; D009638:Norepinephrine